October 11, 2017 News by Patricia Silva, PhD Among MS Patients, ‘Invisible’ Disability Leads to Poor Self-perceived Health, NYU Study Finds Pain, walking problems and fatigue are factors that most strongly lower self-perceived health in multiple sclerosis (MS), researchers at the New York University Langone Medical CenterĀ have found. This challenges current treatment approaches focus mainly on physical disability. It suggests that “invisible disability” may be more important to how patients…
October 2, 2017 News by Ana Belo van Wijk, PhD MS Patients with Poor Diets, Little Exercise Report Higher Pain Levels in Study A clear association was seen between the substantial pain that multiple sclerosis (MS) patients experience and lifestyle choices that either augment or ease that pain, like smoking habits, exercise, and diet and weight, researchers in Australia report. Common co-morbidities associated with MS, such as depression, anxiety, and fatigue, were also…
September 29, 2017 Columns by John Connor One Day at a Time I was going to write about something else, then my MS got in the way. Intellectually, I know MS is very up-and-down, but often when the down hits, I think the worst has happened. I went to my exercise class this week and struggled. Got home and recovered.
September 13, 2017 News by Alice MelĆ£o, MSc GT Biopharma to Develop New PainBrake Tablet Formulation to Treat MS Neuropathic Pain GT BiopharmaĀ has acquired licensing and development rights for PainBrake ā Ā Accu-Break Pharmaceuticalsā non-opioid pain medication to treatĀ dysesthesiaĀ andĀ pain caused by nerve damage in multiple sclerosis (MS). “I am looking forward to initiating the development of PainBrake as we anticipate that many patients with difficult-to-treat neuropathic pain could…
August 30, 2017 Columns by Judy Lynn Is MS Pain Giving You Ants in Your Pants and Bees in Your Bonnet? It took two years and many doctors to finally receive my MS diagnosis. Frequent painful sensations, such as burning, itching, stabbing, and tingling in my arm and shoulder, led my providers and me on a wild-goose chase in search of other problems. When my speech and balance were…
August 11, 2017 Columns by John Connor Walk This Way As I write, I’m pain-free. This is important, but not for the obvious reason. I’m pain-free and can walk āĀ or at least stumble ā about as best as I’ve been able to manage of late. It’s not much, but I can be involved in family life and get…
July 21, 2017 Columns by John Connor The Mouth that Roared After 10-odd ā indeed, increasingly odd ā years, I presumed I’d become something of a gnarled hand at MS. If you read about something on practically a daily basis, you begin to think you’ve got pretty comprehensive knowledge of a subject. Sure, in the past, events happened that I…
July 5, 2017 Columns by Debi Wilson Another MS Symptom: Sciatic Nerve Pain at a Whole New Level Just when I thought I had experienced every multiple sclerosis (MS) symptom possible, another one emerges:Ā sciatic nerve pain. It can happen to anyone, but it is also associated with MS. A couple of months ago, I woke up with a sharp knife-type pain on the upperĀ back side…
June 20, 2017 News by Patricia Silva, PhD AXIM Obtains More Financing for Its Cannabinoid Therapies for MS and Bowel Diseases AXIM BiotechnologiesĀ has secured an additional $4 million in institutional financing to advance clinical trials of itsĀ cannabinoid therapies forĀ multiple sclerosis (MS) andĀ irritable bowel syndrome. Some of the trials involve a chewing-gum therapy delivery system.Ā The financing will let the company continue developing a patented chewing-gum-delivered therapy for pain andĀ spasticity. AXIM…
May 3, 2017 News by Patricia Silva, PhD Axim Signs Deal to Advance Clinical Trials of Cannabis-based MedChew Rx Gum to Treat MS Pain Axim BiotechnologiesĀ recently announced that its U.K. partner, Quay Pharmaceuticals,Ā has secured licenses from the British Home Office to continue developing and importing its medicalĀ cannabinoid product MedChew Rx ā a potential treatment forĀ pain andĀ spasticityĀ in people with multiple sclerosis (MS), among other illnesses. MedChew Rx is a gum…
May 1, 2017 News by Patricia Silva, PhD MS Patients Struggle with Misdiagnosis and Ineffective Treatments, Survey Finds A significant percentage of multiple sclerosis (MS) patients struggle with improper diagnoses and ineffective treatments, a national survey of more than 5,300 patients found. The fifth annual survey, āMS in America 2017,ā was conducted by Health Union between Jan. 25 and March 1, 2017. ItĀ was released through the…
April 21, 2017 Columns by John Connor A Very Hip Story: ‘The Shower That Ate Me’ It was three years since I’d seen my best mate Nigel. The last time had been when we said goodbye at London City Airport after our three-day sozzled sojourn (OK, drunken trip) round the Scottish Isle of Islay. To the uninitiated, a pilgrimage for those who worship peat in their…
March 28, 2017 Columns by Ed Tobias My MS Is Getting to Be a Pain, Literally For most of the 36 years since I was diagnosed with multiple sclerosis I’ve not been bothered by pain. Just lucky, I guess. Until last month. Suddenly, I’ve developed pain in both hips and I don’t know why. The pain is most intense when I first put my feet on…
March 21, 2017 News by Patricia Silva, PhD Physician Assisted Suicide’s Appeal to MS Patients in Unbearable Pain Highlights Urgency in Treating Depression Half of the more than 7,500 multiple sclerosis (MS) patients responding to a recent survey revealed they’dĀ consider physician-assisted suicide if they could no longerĀ enjoy anything that made life worth living. In addition, 65 percent of respondents said they’d definitely or probably let a physician terminate their lives if they were…
February 22, 2017 News by Joana Fernandes, PhD New Compound, BIIB074, May Ease Trigeminal Neuralgia Pain with Fewer Side Effects, Study Says Treatment with a compound called BIIB074 shows promise in reducing pain caused by trigeminal neuralgia ā a Ā condition that occasionallyĀ affects multiple sclerosis (MS) patients ā with few side effects, a new clinical trial finds. The Swiss study, āSafety and efficacy of a Nav1.7 selective sodium channel blockerĀ in Titrigeminal neuralgia:…
February 10, 2017 News by Patricia Silva, PhD Regular Massage Therapy Eases Pain and Fatigue of MS, Small Study Reports Regular massage therapy given peopleĀ withĀ multiple sclerosis (MS)Ā significantly reduced their pain and fatigue, and helped to ease spasticity, a small pilot studyĀ reports. The results further support previousĀ findingsĀ as to the benefits of massage in treatingĀ MS symptoms and improving patients’ quality of life. The study, āImpact of Massage Therapy on Fatigue,…
February 7, 2017 News by Patricia Silva, PhD 95% of MS Patients Open to Marijuana Treatment, 73% Have Tried It Ninety-five percent ofĀ multiple sclerosis (MS)Ā patients believe medical marijuana should be a treatment option, according to aĀ GeneFoĀ online survey. The survey also showed that almost 73 percent had tried it, even though about half said they hadn’t received information from a doctor about its benefits and risks. A National…
January 4, 2017 News by Joana Fernandes, PhD Survey Assesses How Health Professionals Treat Other Health Conditions in MS Patients Healthcare providers frequently assess multiple sclerosis (MS) patients for the development of other health conditions, such as depression, anxiety, pain and sleep disturbance, according to results of a survey-study. The study also includes information about how health professionals treat and counsel MS patients diagnosed with these conditions. The study, ā…
November 18, 2016 News by Patricia Silva, PhD AXIM Biotech to Get U.S. Patent Covering All Cannabinoids in Its Chewing Gums AXIM BiotechnologiesĀ announced that theĀ United States Patent and Trademark Office (USPTO) will be issuing a patent coveringĀ all cannabinoids ā both natural and synthetic ā Ā used in a chewing gum delivery system that may be included in itsĀ cannabinoid-containing, controlled-release chewing gum products. The USPTO has given the company aĀ Notice of…
November 7, 2016 News by Patricia Silva, PhD Testing Stages of Marijuana Gum to Treat Spasticity in MS Can Be Followed Online Medical MarijuanaĀ announced thatĀ Axim Biotechnologies,Ā aĀ cannabinoid-based product developer in which it owns a strategic interest, has released a product pipeline chart highlighting development timelines for its cannabinoid-based therapeutics, including those forĀ Ā multiple sclerosis (MS)Ā patients. The Ā chart illustrates the stage each drug is in, from preclinical testingĀ to, eventually, applications for regulatory…
November 2, 2016 News by Charles Moore AXIM Advances Clinical Trials for MS Relief with Medical Cannabinoid Chewing Gum AXIM BiotechĀ has closed on a private funding round that will enable itĀ to continue clinical trials for a variety of conditions, including its pharmaceutical candidate MedChew Rx, a patented cannabinoid release chewing gum for treating pain and spasticity in multiple sclerosis (MS). According to a press releaseĀ from SECFilings.com,…
October 28, 2016 News by Patricia Silva, PhD AXIM Moving Ahead with Testing of Cannabinoid Products, Including Chewing Gum for MS Patients AXIM Biotechnologies Ā announced it has secured financing from private sources to continue its testing of medicalĀ cannabinoid products as potential treatments forĀ multiple indications, includingĀ pain and spasticity in people with multiple sclerosis (MS). Specifically, AXIM Ā is testing pharmaceutical delivery systems andĀ active ingredients for itsĀ medical marijuana line. āThis financing provides us with…
October 12, 2016 Columns by Judy Lynn An MS, Migraine, Marching Band Kind of Day! I work full time in public health, and some days are spent āout in the fieldā visiting clients in their homes. It requires careful planning to ensure that I have adequate water, food, medications, and layers of clothing for homes that are too hot or too cold.Ā I research…
October 4, 2016 News by Patricia Silva, PhD Mindfulness Training Seen to Help People Adjust to Chronic Ills Like MS A researcher atĀ De Montfort University Leicester (DMU)ās School of Nursing and Midwifery found that the practice of mindfulness helps people with long-term medical conditions, such as multiple sclerosis, to manage their diagnosis. The study,Ā āStarting where I am: a grounded theory exploration of mindfulness as a facilitator…
September 15, 2016 News by Marina Anastasiou Montel Williams Starts Medical Cannabis Company for MS and Other Chronic Diseases Montel Williams, a Naval Academy graduate diagnosed with multiple sclerosis (MS) in 1999 , recently announced the launch of a line of high-quality medical cannabis products under the brandĀ name LenitivLabsĀ byĀ Lenitiv Scientific. The former television host and wellness advocate has been particularly vocal when it comes to supportĀ the use of medical…
August 16, 2016 News by Charles Moore Earth Life Sciences Acquiring Maker of Medicinal Cannabis Oil Treatments for MS Earth Life SciencesĀ (ELS), aĀ venture capital and management firm based in Quebec, announced that it is partnering with a cannabis oil-based nutraceutical company, with an agreement in place to acquire that company and establish a new division. The resulting entity will beĀ an organic medical marijuana oils (CBD) producer that willĀ develop products…
August 4, 2016 News by Ćzge Ćzkaya, PhD TENS Seen as Low Cost and Accessible Way to Ease Spasticity in MS Patients Transcutaneous electrical nerve stimulation (TENS) might be an option to treat spasticity, one of the more common symptoms of multiple sclerosis (MS), according to a literature review conducted by researchers from Universidad de Castilla la Mancha, Toledo and Hospital Nacional de ParaplĆ©jicos de Toledo, in Spain.
June 17, 2016 Columns by admin Optic Neuritis in MS So Difficult To See Optic neuritis is one of the symptoms of which those of us who live with multiple sclerosis on a daily basis know can set us apart from others. We are fully, and often painfully, aware that everyone is different. We all experience a different array of symptoms to similarly different…
February 2, 2016 News by admin Individual with PPMS Shares His Experience of Undergoing Stem Cell Therapy Geoff Flynn,Ā 42, was diagnosed with multiple sclerosis (MS) two and a half years ago. As unsettling as that diagnosis was, more troubling ā both then and now ā were the five long years of struggle it took for him to get a proper evaluation as to the cause ofĀ his neurological…
January 11, 2016 News by Charles Moore Can Cannabinoid Chewing Gum Treat Multiple Sclerosis Pain and Spasticity? MedChew Rx, by AXIM Biotechnology,Ā the world’s first patented cannabinoid release chewing gum for pain and spasticity in multiple sclerosis (MS), is movingĀ into clinical testing. If all goes well, the company plans for a global release date ofĀ 2017. Medical cannabis is believed to have considerable promise as a therapy for…